No Data
The new drug development time is cut in half, diagnoses are more accurate, industry barriers are lowered... AI is transforming the Medical Industry in China.
On February 26, Deutsche Bank Analyst Cyrus Ng released a report stating that the entire Medical Industry in China, from drug development and diagnostics to Hospital management, will benefit from the AI revolution.
The wave of AI in Medical is sweeping: the potential of the macromolecule new drug market is highlighted and imaging products are "going overseas" into Emerging Markets | Focus
① Some executives from pharmaceutical companies have stated that "currently, the discovery of small molecule drugs is very challenging; finding potential molecules and structures is already quite difficult, while there is still significant potential in the discovery and design of large molecule new drugs." ② Currently, the application maturity of AI technology in the imaging field is relatively high, and relevant manufacturers have revealed that the market potential for AI imaging large models in Belt and Road Initiative Concept countries is quite extensive.
AI hotspots continue to boost! Most Medical stocks in Hong Kong strengthen, with Micro-invasion Siasun Robot&Automation rising over 20%.
How does Sister Wood perceive this hot topic of AI Medical? What positive impacts will the emergence of DeepSeek bring to the medical field?
Hong Kong stock Concept tracking | Local policies intensify layout of Brain-computer Interface Industry commercialization process accelerates (with Concept stocks)
At the beginning of the year, Peking and Shanghai released action plans, providing clear development directions regarding regulatory policies, clinical trials, industrial clusters, commercialization, and the Industry Chain in the Brain-computer Interface field.
Hong Kong stock concept tracking | The first patient in Shanghai to receive a Brain-computer Interface implant "can now drink water controlled by the brain". There are more clinical trials of domestic Brain-computer Interfaces. (Included concept stocks)
Next year, China will carry out 30 to 50 clinical trial implantation surgeries for domestic Brain-computer Interfaces.
Innovation genes stimulate intrinsic motivation, Xinwei Medical-B (6609.HK) was awarded the 'Annual Innovation Award'.
Innovation is undoubtedly the lifeblood of a company's survival and development. In today's rapidly changing business environment, companies must continuously innovate to maintain competitiveness and achieve self-breakthroughs. As Darwin said, "It is not the strongest species that survive, nor the most intelligent, but the most responsive to change." Therefore, how companies strengthen their core competitiveness, continuously enhance their technology capabilities around innovation, lead industry development, and even promote industrial revolutions will become the key to standing out. Recently, at the "Gelonghui · Global Investment Carnival · 2025" event, Xinwei Medical was awarded the "Annual Innovation Award," highlighting its.
